Gravotta E

No ORCID on file · 3 papers in corpus
Comparative outcomes of conventional follitropin delta 15 µg/day versus follitropin alfa 225 IU/day for ovarian stimulation: results from an exploratory post hoc analysis of Spanish participants from the ADAPT-1 randomized controlled trial
Frontiers in reproductive health
other 2026
Efficacy of follitropin delta in potential low responders: a pooled analysis of individual patient data from five randomized controlled trials
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1880515

OBJECTIVES: This study evaluated the efficacy of individualized follitropin delta dosing in patients with potential low response, defined by anti-Müllerian hormone (AMH) level <9 pmol/L, undergoing ovarian stimulation for assisted reproduct…

observational 2025
Effectiveness and safety of follitropin delta in routine clinical practice in the Nordics and Switzerland (the NORSOS study): a prospective non-interventional study.
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1613680

BackgroundFollitropin delta is the first approved human recombinant follicle-stimulating hormone treatment administered through an algorithmic individualized dosing regimen based on body weight and anti-Müllerian hormone (AMH) levels. This …